RecruitingNCT07487610

Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older

Evaluation of the Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older


Sponsor

Sultan 1. Murat State Hospital

Enrollment

450 participants

Start Date

Mar 17, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study aimed to determine the frequency of neuropathic pain in individuals aged 80 years and older and to evaluate the relationship between neuropathic pain and comprehensive geriatric assessment parameters.


Eligibility

Min Age: 80 Years

Inclusion Criteria3

  • Age 80 years or older
  • Full cooperation
  • Complete comprehensive geriatric assessment parameters

Exclusion Criteria5

  • Patients with dementia classified as CDR-2 or CDR-3 according to the Clinical Dementia Rating (CDR) Scale
  • Patients who have experienced an acute illness within the last 1 month (e.g., infection, fracture, or cerebrovascular disease)
  • Patients with a psychotic disorder
  • Patients with severe hearing loss
  • Patients with a history of malignancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDetailed geriatric assessment

The patients' demographic characteristics, comorbid diseases, and laboratory parameters routinely requested from each patient within the last 3 months, including TSH, vitamin D, vitamin B12, HbA1c, hemoglobin, folic acid, and GFR levels, will be recorded. During the outpatient clinic visit, the presence of neuropathic pain will be assessed using the Douleur Neuropathique-4 (DN4) questionnaire. Pain intensity will be evaluated using the Visual Analog Scale (VAS), and the average pain severity over the last week will be recorded. The use of medications that may affect pain severity and that have been used regularly by the patients for the last 3 months will also be assessed (antiepileptics, nonsteroidal anti-inflammatory drugs, paracetamol, and antidepressants). The patients will undergo mood assessment, evaluation of basic and instrumental activities of daily living, neurocognitive assessment, frailty assessment, and nutritional assessment.


Locations(1)

Sultan 1. Murat State Hospital

Edirne, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07487610


Related Trials